Case Studies
Psychedelic Alpha Released Q1 2026 Psychedelic Drug Development Bullseye Charts
LOS ANGELES – Psychedelic Alpha, the data-focused research and analysis ...
Medicare’s CBD Shift Signals Validation—But a Looming Hemp Ban Clouds the Path for Seniors
NEW YORK- For decades, seniors managing chronic pain, inflammation, anxiety, or ...
DEA Increases Psychedelics Production Quotas for 2026
WASHINGTON – The Drug Enforcement Administration has approved expanded production ...
Psilocybin Review Points to Rapid Relief for Treatment-Resistant Depression
LOS ANGELES – A new systematic review of clinical studies underscores psilocybin's potential to deliver quick and lasting reductions in depressive symptoms, offering a targeted option for patients who see little benefit from standard medications. ...
Vireo Takes 86% Stake in Schwazze’s Convertible Notes in $62M Deal
DENVER – Vireo Growth Inc., a multistate Cannabis operator, has entered into definitive agreements to purchase about 86% of the senior secured convertible notes held by Medicine Man Technologies Inc., which operates as Schwazze, for ...
France Upholds Pesticide Ban, Guaranteeing Survival of the Bees
LOS ANGELES- Over the past decade, France has stood at the center of Europe’s fight to protect pollinators from the devastating effects of pesticides. In 2018, the nation became the first EU member to ban ...
Case Study: Grupo Flor: A Cannabis Turnaround Driven by Strategic Focus
SALINAS- When Mark Collins joined Grupo Flor as Chief Financial Officer, the California-based vertically integrated Cannabis company was in severe financial and operational distress. The business held multiple licenses across retail, cultivation, manufacturing, and distribution—far ...
Cannabis Stocks Rally as U.S. Rescheduling Debate Heats Up
LOS ANGELES — For the first time in more than a year, cannabis stocks are enjoying a sustained rally. Exchange-traded funds focused on the sector have climbed sharply in recent weeks, and several of the ...
Did Psilocybin Arrive From Outer Space? New Genomic Study Opens the Door to a Cosmic Possibility
LOS ANGELES — The psychedelic compound psilocybin has long intrigued researchers for its potential to treat mental health conditions, but a groundbreaking study is now shedding new light on where these mushrooms came from—and it’s ...
Will Hope Fuel Cannabis Industry Growth Beyond Q2 2025?
LOS ANGELES – If you’ve been scrolling through the latest updates on the Highly Capitalized Network’s website or LinkedIn, you’ve likely caught the wave of Q2 2025 earnings reports sparking cautious optimism across the Cannabis ...
Psilocybin Review Points to Rapid Relief for Treatment-Resistant Depression
LOS ANGELES – A new systematic review of clinical studies underscores psilocybin's potential to deliver quick and lasting reductions in depressive symptoms, offering a targeted option for patients who see little benefit from standard medications. ...
Vireo Takes 86% Stake in Schwazze’s Convertible Notes in $62M Deal
DENVER – Vireo Growth Inc., a multistate Cannabis operator, has entered into definitive agreements to purchase about 86% of the senior secured convertible notes held by Medicine Man Technologies Inc., which operates as Schwazze, for ...
France Upholds Pesticide Ban, Guaranteeing Survival of the Bees
LOS ANGELES- Over the past decade, France has stood at the center of Europe’s fight to protect pollinators from the devastating effects of pesticides. In 2018, the nation became the first EU member to ban ...
